Top Oversight Dem pushes for White House opioid briefing

Top Oversight Dem pushes for White House opioid briefing
© Moriah Ratner

The top Democrat on the House Oversight and Government Reform Committee is calling for the White House to brief the panel on its efforts to implement recommendations from the president's opioid commission.

Rep. Elijah CummingsElijah Eugene CummingsTop House Dem claims Judiciary chairman's DOJ, FBI subpoena is invalid Republicans tear into IG finding on Clinton probe Cummings slams family separations: 'We will not keep kids in child internment camps' MORE (D-Md.) wrote a letter to Oversight Chairman Trey GowdyHarold (Trey) Watson GowdyTop House Dem claims Judiciary chairman's DOJ, FBI subpoena is invalid The Hill's Morning Report — Sponsored by PhRMA — GOP lawmakers race to find an immigration fix Republicans tear into IG finding on Clinton probe MORE (R-S.C.) on Friday urging him to request the briefing from presidential counselor Kellyanne ConwayKellyanne Elizabeth ConwayFox's Guilfoyle: Women in Trump administration 'dealt an unfair hand' by 'dishonest' media The Hill's Morning Report — Sponsored by PhRMA — Outcry raises pressure on GOP for immigration fix White House faces growing outcry over migrant family policies MORE, who has helmed the White House's efforts to combat the opioid epidemic.

“I understand that President TrumpDonald John TrumpCNN analyst Kirsten Powers: Melania's jacket should read 'Let them eat cake' CNN's Cuomo confronts Lewandowski over 'womp womp' remark Sessions says FBI agent Peter Strzok no longer has his security clearance MORE has designated Kellyanne Conway as his point person on this issue, so her input would help the Committee with its ongoing efforts to evaluate the status of the Commission’s recommendations,” Cummings wrote.

ADVERTISEMENT

Cummings expressed frustration at a prior effort to request a briefing from the White House, alleging that Gowdy’s staff declined to help make the request. Cummings also claimed that Gowdy requested a briefing from the Office of National Drug Control Policy (ONDCP) but that the letter was sent without asking Cummings to join.

Though committee staff from both parties met with ONDCP earlier this week, Cummings wrote that it was vital to also secure a briefing with the administration to hear about its efforts to implement the opioid commission's nearly 60 recommendations on how to combat the epidemic plaguing the U.S. Those recommendations were issued on Nov. 1.

“One problem with speaking only with ONDCP is that President Trump and his top advisors have been trying to decimate ONDCP since the first days of his Administration,” Cummings noted.

A spokesperson for Gowdy did not immediately return a request for comment.

The Office of Management and Budget was weighing proposing to nearly eliminate ONDCP in the president’s budget last year. The plan wasn’t ultimately included, as it received backlash from lawmakers and advocates.

This year, the president’s budget released Monday proposes major changes to ONDCP — moving two of its main grant programs out of the office and into other departments.

Additional news reports have suggested a lack of senior leadership at ONDCP, Cummings wrote. The White House appointed an acting director last week.